Randomized trial · people

Pramlintide lowered post-meal glucagon and glucose in type 2 diabetes

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In people with type 2 diabetes, pramlintide blunted the glucagon spike after a meal, whether or not they used insulin.

Kind
Randomized trial
Studied in
People
Number studied
24
Published
2002
Journal
Horm Metab Res

What they tested

The team tested whether pramlintide reduces the high levels of the hormone glucagon after meals that are common in people with type 2 diabetes.

How the study was done

A randomized, single-blind, placebo-controlled crossover trial in 24 people with type 2 diabetes: 12 used insulin and 12 did not. Each person had the same standard mixed meal on 2 occasions, once during a five-hour intravenous (into a vein) infusion of placebo and once during a pramlintide infusion at 100 microg/h, in random order.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

With placebo, blood glucose and glucagon both rose a lot after the meal. With pramlintide, the post-meal rises in glucose and glucagon were both significantly smaller after the same meal (p < 0.05 for all). This held in both the insulin-treated and the non-insulin-treated groups. The authors concluded that lower glucagon likely helps explain how pramlintide lowers blood sugar after meals.

What it doesn’t show

This was a small trial with a single meal test on each treatment, using a five-hour intravenous infusion, so it does not show effects over weeks or months of use. The link between lower glucagon and lower blood sugar is the authors' interpretation, not something the trial tested directly.

The paper

Fineman et al. The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res. 2002.

The compound

More studies on Pramlintide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo